Balingit, Kemberly M.
HRN: 27-38-09 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2025
CEFUROXIME 750MG (VIAL)
08/04/2025
08/10/2025
IV
750mg
Q12
Uti
Checking Initial Appropriateness
08/05/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/05/2025
08/06/2025
IV
500mg
Q8
S/p CS
Checking Initial Appropriateness